Federal Register / Vol. 72, No. 40 / Thursday, March 1, 2007 / Notices 9343 

The seminar helps to implement the 

objectives of section 903 of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393) and the FDA Plan for Statutory 

Compliance, which includes working 

more closely with stakeholders and 

ensuring access to needed scientific and 

technical expertise. The seminar also 

furthers the goals of the Small Business 

Regulatory Enforcement Fairness Act 

(Public Law 104–121) by providing 

outreach activities by Government 

agencies directed at small businesses. 

The following topics, as well as 

others, will be discussed at the seminar: 

• Doing business in a regulated 

industry; 

• Organizational structure of FDA; 

• Overview of the quality system 

regulation; 

• Design controls; 

• Documents, records, and change 

control; 

• Purchasing controls and acceptance 

activities; 

• Production and process control; 

• Corrective and preventive actions; 

• Complaints, medical device reports, 

corrections, and recalls; 

• Compliance issues; 

• Management responsibility; 

• Interacting with FDA—Where do 

you go for assistance? 

• General question and answer 

session; 

• Manufacturers and suppliers—the 

chain regulatory responsibility; 

• Reimbursement of medical 

technology; 

• The AdvaMed code of ethics; and 

• Fraud and abuse. 

Dated: February 23, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–3619 Filed 2–28–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, and/or contract proposals, 

the disclosure of which constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, ‘‘Early 

Diagnosis Using Nanotechnology-Based 

Imaging & Sensing’’ and ‘‘Multifunctional 

Therapeutics ‘‘Based on Nanotechnology’’. 

Date: March 14, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Marriott Bethesda, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Joyce C. Pegues, PhD., 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 7149, 

Bethesda, MD 20892, 301/594–1286, 

peguesj@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI 

Community Networks Program. 

Date: March 22–23, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Bratin K. Saha, PhD., 

Scientific Review Administrator, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8041, 

Bethesda, MD 20892, (301) 402–0371. 

sahab@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Prevention, 

Control and Population Science SEP. 

Date: March 28, 2007. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Conference Room 210, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Jeannette F. Korczak, PhD., 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8115, Bethesda, MD 20892, 301–496–9767. 

korczakj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS). 

Dated: February 21, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–923 Filed 2–28–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders, 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, Blueprint 

K18—Neurodegeneration. 

Date: March 16, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Christine A. Livingston, 

PhD, Scientific Review Administrator, 

Division of Extramural Activities, National 

Institutes of Health/NIDCD, 6120 Executive 

Blvd.—MSC 7180, Bethesda, MD 20892, 

(301) 496–8683, livingsc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, 

HHS). 

Dated: February 21, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–924 Filed 2–28–07; 8:45 am] 

BILLING CODE 4140–01–M 


rmajette on PROD1PC67 with NOTICES